채용
岗位职责:
- 负责带领实验室QA团队监管QC实验室现场;
- 负责带领实验室QA团队审核QC实验室管理文件与操作SOP;
- 负责带领实验室QA团队负责审核QC实验室放行检测数据与记录;
- 负责带领实验室QA团队负责审核QC实验室稳定性数据 与记录;
- 负责带领实验室QA团队审核QC实验室环境监测数据与记录;
- 负责带领实验室QA团队审核QC实验室无效分析,偏差与OOS事件的;
- 负责带领实验室QA团队复核QC实验室COA;
- 负责带领实验室QA团队审核QC实验室变更;
- 负责合同实验室的现场审计;
- 负责带领实验室QA团队审核分析方法验证/转移方案与报告,及相关数据与记录;
- 负责协助处理产品批放行;
- 完成上级领导交付的其他工作。
任职要求:
- 本科及以上学历,生物工程、生物技术及其他制药相关专业;
- 制药企业QC工作经验5-8年(硕士可放宽至3-5年)实验室QA工作满3-5年以上;
- 制药行业质量管理相关工作5年以上,其中生物药分析经验3年以上;
- 英文CET-4以上,良好的英文听说读写能力。
총 조회수
0
총 지원 클릭 수
0
모의 지원자 수
0
스크랩
0
비슷한 채용공고

Application Engineer Director – Mechanical SDA
Cadence · 2 Locations

Manufacturing Process Improvement Lead (PG 31B)
Johnson & Johnson · Xian, Shaanxi, China

Production Manager
Trane Technologies · Taicang, Jiangsu, China
Manufacturing Engineering Director
Nextracker · China, Zhuhai

Category Manager - Electromechanical
ABB · 2 Locations
BioNTech 소개

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
직원 수
Mainz that develops immunotherapies
본사 위치
$21.7B
기업 가치
리뷰
4.0
10개 리뷰
워라밸
2.5
보 상
3.8
문화
4.2
커리어
3.5
경영진
3.2
75%
친구에게 추천
장점
Innovative and cutting-edge projects
Great team and collaborative environment
Excellent benefits and flexible schedule
단점
Long working hours and high workload
Fast-paced and high-pressure environment
Management and communication issues
연봉 정보
70개 데이터
L2
L3
L4
L5
L6
Mid/L4
Intern
L2 · Data Scientist L2
0개 리포트
$53,767
총 연봉
기본급
$21,507
주식
$26,884
보너스
$5,377
$37,637
$69,897
면접 경험
1개 면접
난이도
3.0
/ 5
소요 기간
14-28주
면접 과정
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
자주 나오는 질문
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
뉴스 & 버즈
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
2d ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
4d ago
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
medwatch.com
News
·
1w ago
BioNTech and DualityBio report positive data for trastuzumab pamirtecan - Clinical Trials Arena
Clinical Trials Arena
News
·
1w ago